InsidersTradesSigma
Total declarations
Company
▲ Purchases (25 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
25
Disclosed sells
0
T+90 hit rate
6%
T+90 mean return
-32.6%
Across 33 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sullivan James David, Directeur Juridique. Director active across 1 company, notably BIO KEY International INC. In total, 38 reports have been published. Split: 25 buys · 0 sell. Total volume traded: €110k. Activity tracked since 20 May 2021. The latest transaction was filed on 22 August 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations38 total
250 sharesCommon StockSEC:0001437749-26-022527:0
10,000 shares@ US$0.775.3% of flowCommon StockSEC:0001437749-25-027787:0
Ideal exit: 19 May 2026 (T+270)
139 shares@ US$1.400.1% of flowCommon StockSEC:0001437749-25-000211:0
22,500 shares0Common StockSEC:0001437749-24-024509:0
139 shares@ US$1.3940.1% of flowCommon StockSEC:0001437749-24-022006:0
139 shares@ US$2.550.3% of flowCommon StockSEC:0001437749-24-000423:0
20,000 shares@ US$0.1652.4% of flowCommon StockSEC:0001437749-23-033447:0
Ideal exit: 26 Aug 2024 (T+270)
17,609 shares@ US$0.1652.1% of flowCommon StockSEC:0001437749-23-033092:1
Ideal exit: 20 Aug 2024 (T+270)
959 shares@ US$0.1730.1% of flowCommon StockSEC:0001437749-23-033092:2
Ideal exit: 20 Aug 2024 (T+270)
1,100 shares@ US$0.17310.1% of flowCommon StockSEC:0001437749-23-033092:3
Ideal exit: 20 Aug 2024 (T+270)
9,803 shares@ US$0.1641.2% of flowCommon StockSEC:0001437749-23-033092:4
Ideal exit: 23 Aug 2024 (T+270)
100 shares@ US$0.180.0% of flowCommon StockSEC:0001437749-23-033092:5
Ideal exit: 23 Aug 2024 (T+270)
100 shares@ US$0.17990.0% of flowCommon StockSEC:0001437749-23-033092:6
Ideal exit: 23 Aug 2024 (T+270)
10,000 shares@ US$0.161.2% of flowCommon StockSEC:0001437749-23-033092:0
Ideal exit: 20 Aug 2024 (T+270)
228,000 shares@ US$0.17530.2% of flowCommon StockSEC:0001437749-23-029811:0
Ideal exit: 26 Jul 2024 (T+270)
96 shares@ US$0.530.0% of flowCommon StockSEC:0001437749-23-026164:0
Ideal exit: 11 Jun 2024 (T+270)
1,200 shares@ US$0.520.5% of flowCommon StockSEC:0001437749-23-025634:0
Ideal exit: 7 Jun 2024 (T+270)
3,800 shares@ US$0.531.5% of flowCommon StockSEC:0001437749-23-025634:1
Ideal exit: 7 Jun 2024 (T+270)
4,000 shares@ US$0.5281.6% of flowCommon StockSEC:0001437749-23-025634:2
Ideal exit: 7 Jun 2024 (T+270)
5,000 shares@ US$0.552.0% of flowCommon StockSEC:0001437749-23-025190:0
Ideal exit: 27 May 2024 (T+270)
30,000 shares0Common StockSEC:0001437749-23-024954:0
2,500 shares@ US$0.49730.9% of flowCommon StockSEC:0001437749-23-019332:0
2,500 shares@ US$0.49730.9% of flowCommon StockSEC:0001437749-23-000718:0
968 shares@ US$1.571.2% of flowCommon StockSEC:0001437749-22-022432:0
Ideal exit: 9 Jun 2023 (T+270)
2,377 shares@ US$1.522.9% of flowCommon StockSEC:0001437749-22-022164:0
Ideal exit: 5 Jun 2023 (T+270)
25 of 38 declarations
About Sullivan James David
James David Sullivan is the Chief Legal Officer at Bio Key International Inc. He is responsible for managing the legal affairs of the company, ensuring compliance and protecting Bio Key's interests. His expertise is essential in navigating a complex regulatory environment.
